In a large clinical trial, another free radical scavenger, NXY-059 also reduced tPA-induced HT in humans (Table 2) (Lees et al., 2006); however, it failed to reduce disability after stroke in a subsequent trial (Shuaib et al., 2007). Here, PLAT is linked to Stroke.